Overview
Status
Active
Registry date
2022-08-30
Share capital
5,000.00 PLN
Registered address
ul. Nowa 5, 21-200 Parczew, Poland
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 13 days early.
- 202524/06/2026
- 202408/07/2025
- 202303/07/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 297.99kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 75.01kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 211.87kMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 191.77kMedianUSD 609.79kAverageUSD 11.85m
Industry
Authorized Representatives
Andrei Kharuzhka – Management Board Member
Henadzi Kharuzhka – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrei Kharuzhkaage 36 | 50 | $675.31 | 50% |
Henadzi Kharuzhkaage 60 | 50 | $675.31 | 50% |
Andrei Kharuzhka and Henadzi Kharuzhka hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-09-16.
67 1090 2590 0000 0001 5151 0075
82 1090 2590 0000 0001 5150 9417
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| LubfarmS.A. | $123,208,945.21 | lubfarm.pl | ||
| Camedica Paweł Harasimiuksp. k. | $18,691,613.15 | camedica.pl | ||
| Medcomplexsp. z o.o. | $5,193,830.09 | medcomplex.pl | ||
| Przedsiębiorstwo Zaopatrzenia Lecznictwa Cezal Lublinsp. z o.o. | $4,277,670.93 | cezal.lublin.pl | ||
| Bio-Novumsp. z o.o. | $3,459,663.10 | bio-novum.com | ||
| Myderm Laboratoriessp. z o.o. | $177,750.48 | myderm.com.pl | ||
| GROW Pharmasp. z o.o. | $15,020.86 | growpharma.pl | ||
| PetnovellS.A. | $0.00 | petnovell.pl | ||
| Dental Łukasiksp. j. | – | dental.lublin.pl |
FAQ
The main business activity of Dentpar focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on August 30, 2022.
The headquarters is located at: ul. Nowa 5, 21-200 Parczew.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $202,001 in 2024, which is a decrease of 50.5% compared to 2023.
Yes, in 2024 the company was profitable, achieving a net profit of $30,792, meaning the company decreased its profit by 67.2%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $147,864 in 2024, representing 90% of all operating expenses.
Last updated: 2026-06-24